ScienceDaily February 10, 2013. National Institutes of Health (NIH) scientists have identified a promising lead for developing a new type of drug to treat infection caused by Staphylococcus aureus, notable drug-resistant pathogen. They have discovered a transport system for toxins that are thought to contribute to severe staph infections – phenol-soluble modulins (PSMs). The transport system, Pmt, is common to all S. aureus PSMs and critical for bacterial proliferation and disease development in a mouse model. Their experiments suggest that a drug interfering with Pmt’s function could not only prevent production of the PSM toxins, but also directly lead to bacterial death. This research is reported in Nature Medicine.
adaptive immunity
Alzheimer's Disease
antibiotics
antibodies
apoptosis
autism
bacteria
Breast cancer
C. elegans
cancer
chromatin
circadian clocks
CRISPR
cryo-electron microscopy
DNA
Drosophila
Epigenetics
eukaryotes
evolution
gene expression
Genomics
HIV
HIV AIDS
human genome
immunity
metabolism
microRNA
miRNA
mitochondria
mRNA
neural circuits
neurodegeneration
neurons
obesity
optogenetics
Parkinson's Disease
pathogenesis
proteomics
ribosomes
RNA
Saccharomyces cerevisiae
stem cells
synapses
transcription
vaccines